Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 3, 2004, Pages 746-754

  Konstantinov, Igor E ^a   Coles, John G ^a,c   Boscarino, Cathy ^a   Takahashi, Mark ^b   Goncalves, Jason ^b   Ritter, Julia ^a   Van Arsdell, Glen S ^a   Gruber, Peter J ^d   Jonas, Richard A ^d   Allen, Bradley ^d  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; COMPLEMENTARY DNA; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LIQUID NITROGEN; PHOSPHOPROTEIN PHOSPHATASE 2A; RAP PROTEIN; STAT PROTEIN;

ARTICLE; CHILD; CLINICAL ARTICLE; DNA HYBRIDIZATION; DNA MICROARRAY; FEMALE; FLUORESCENCE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEART MUSCLE; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART SURGERY; HUMAN; HUMAN TISSUE; INFANT; MALE; NEWBORN; PATHOGENESIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RNA ISOLATION; TREATMENT OUTCOME;

EID: 12144291416     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.08.056     Document Type: Article

References (46)

1. Shi Y, Baker JE, Zhang C, Tweddell JS, Su J, Pritchard KA Jr. Chronic hypoxia increases endothelial nitric oxide synthase generation of nitric oxide by increasing heat shock protein 90 association and serine phosphorylation. Circ Res. 2002;91:300-6.
2. Konorev E, Tarpey M, Joseph J, Baker J, Kalyanaraman B. S-Nitrosoglutathione improves functional recovery in the isolated rat heart after cardioplegic ischemic arrest-evidence for a cardioprotective effect of nitric oxide. J Pharmacol Exp Ther. 1995;274:200-6.
3. Madan A, Varma S, Cohen HJ. Developmental stage-specific expression of the alpha and beta subunits of the HIF-1 protein in the mouse and human fetus. Mol Genet Metab. 2002;75:244-9.
4. Bitar FF, Bitar H, El Sabban M, Nasser M, Yunis KA, Tawil A, et al. Modulation of ceramide content and lack of apoptosis in the chronically hypoxic neonatal rat heart. Pediatr Res. 2002;51:144-9.
5. Casey TM, Pakay JL, Guppy M, Arthur PG. Hypoxia causes down-regulation of protein and RNA synthesis in noncontracting mammalian cardiomyocytes. Circ Res. 2002;90:777-83.
6. Hauck L, Hansmann G, Dietz R, von Harsdorf R. Inhibition of hypoxia-induced apoptosis by modulation of retinoblastoma protein-dependent signaling in cardiomyocytes. Circ Res. 2002;91:782-9.
7. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001;98:5116-21.
8. Holloway AJ, van Laar RK, Tothill RW, Bowtell DDL. Options available-from start to finish-for obtaining data from DNA microarrays II. Nat Genet. 2002;32:481-9.
9. Dempsey AA, Dzau VJ, Liew CC. Cardiovascular genomics: estimating the total number of genes expressed in the human cardiovascular system. J Mol Cell Cardiol. 2001;10:1879-86.
10. Friddle CJ, Koga T, Rubin EM, Bristow J. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci U S A. 2000;97:6745-50.
11. Hwang J-J, Allen PD, Tsent GC, et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics. 2002;10:31-44.
12. Lowes BD, Gilbert EM, Abraham WT, Minobe WA, Larrabee P, Ferguson D, et al. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents. N Engl J Med. 2002;346:1357-65.
13. Cook SA, Rosenzweig A. DNA microarrays: implications for cardiovascular medicine. Circ Res. 2002;91:559-64.
14. Brunner-La Rocca HP, Kiowski W, Ramsay D, Sutsch G. Therapeutic benefits of increasing natriuretic peptide levels. Cardiovasc Res. 2001;51:510-20.
15. Boomsma F, van den Meiracker AH. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res. 2001;51:442-9.
16. Chen YF, Durand J, Claycomb WC. Hypoxia stimulates atrial natriuretic peptide gene expression in cultured atrial cardiocytes. Hypertension. 1997;29:75-82.
17. Chen YF, Elton TS, Bounelis P, Jin H, Oparil, S. Acute hypoxia increases atrial natriuretic peptide (ANP) gene expression in left atrium of the rat. Clin Res. 1993;38:18.
18. Cher YF, Elton TS, Bounelis P, Jin H, Oparil S. Altered atrial natriuretic peptide gene expression in atria of rats adapted to chronic normobaric hypoxia. Am J Hypertens. 1989;2:45.
19. Kiemer AK, Weber NC, Furst R, Bildner N, Kulhanek-Heinze S, Vollmar AM. Inhibition of p38 MAPK activation via induction of MKP-1 atrial natriuretic peptide reduces TNF-α-induced actin polymerization and endothelial permeability. Circ Res. 2002;90:874-81.
20. Hirohisa O, Hitoshi H, Shigetoshi M, Yuklya N, Masataka Y, Kenichi N, et al. Alpha-human atrial natriuretic peptide mimics ischemic preconditioning through NO-PKC-mitochondrial KATP channel dependent mechanism. Circulation. 2002;106:II-345.
21. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, Wagner H. HSP70 as endogenous stimulus of the toll/interleukin-1 receptor signal pathway. J Biol Chem. 2002;277:15107-12.
22. Vincent AM, Feldman EL. Control of cell survival by IGF signaling pathways. Growth Horm IGF Res. 2002;12:193-7.
23. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension. 2000;35:19-24.
24. Klinger JR, Petit RD, Curtin LA, Warburton RR, Wrenn DS, Steinhelper ME, et al. Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J Appl Physiol. 1993;75:198-205.
25. Cantin M, Gutkowska J, Thibault G, Milne RW, Ledoux S, Min Li S, et al. Immunocytochemical localization of atrial natriuretic factor in the heart and salivary glands. Histochemistry. 1984;80:113-27.
26. Nemer M, Lavigne JP, Drouin J, Thibault G, Gannon M, Antakly T. Expression of atrial natriuretic factor gene in heart ventricular tissue. Peptides. 1986;6:1147-52.
27. Kim SH, Han JH, Cao C, Kim SZ, Cho KW. Postnatal changes in inhibitory effect of C-type natriuretic peptide on secretion of ANP. Am J Physiol Regul Integr Comp Physiol. 2002;282:R1672-9.
28. Gergs U, Fabritz L, Matus M, Boknik P, Schmitz W, Neumann J. Impaired ventricular contractility and cardiac hypertrophy in transgenic mice overexpressing the protein phosphatase 2A in the heart. Circulation. 2002;106:11-99.
29. 2+-calmodulin-dependent protein kinase IV and protein phosphatase 2A. Science. 1998;280:1258-61.
30. Yellaturu CR, Bhanoori M, Neeli I, Rao GN. N-Ethylmaleimide inhibits platelet-derived growth factor BB-stimulated Akt phosphorylation via activation of protein phosphatase 2A. J Biol Chem. 2002;277:40148-55.
31. Sano M, Abdellatif M, Oh H, Xie M, Bagella L, Giordano A, et al. Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy. Nat Med. 2002;8:1310-7.
32. Fu M, Zhang J, Lin Y, Zhu X, Ehrengruber MU, Chen YE. Early growth response factor-1 is a critical transcriptional mediator of peroxisome proliferator-activated receptor-γ1 gene expression in human aortic smooth muscle cells. J Biol Chem. 2002;227:26808-14.
33. Takano H, Nagai T, Asakawa M, Toyozaki T, Oka T, Komuro I, et al. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-α expression in neonatal rat cardiac myocytes. Circ Res. 2000;87:596-602.
34. Khachigian LM, Linder V, Williams AJ, Collins T. Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science. 1996;271:1427-31.
35. Biesiada E, Razandi M, Levin E. Egr-1 activates basic fibroblast growth factor transcription. J Biol Chem. 1996;271:18576-81.
36. Inoue M, Itoh H, Tanaka T, Chun TH, Doi K, Fukunaga Y, et al. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler Thromb Vasc Biol. 2001;21:560-6.
37. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol. 2002;12:258-66.
38. Feduchi E, Gallego MI, Lazo PA. The human zinc-finger protein-7 gene is located 90 kb 3′ of MYC and is not expressed in Burkitt lymphoma cell lines. Int J Cancer. 1994;58:855-9.
39. Damjanovski S, Huynh M-H, Motamed K, Sage EH, Ringuette M. Regulation of SPARC expression during early Xenopus development: evolutionary divergence and conservation of DNA regulatory elements between amphibians and mammals. Dev Genes Evol. 1998;207:453-61.
40. Masson S, Arosio B, Luvara G, Gagliano N, Fiodaliso F, Santambrogio D, et al. Remodelling of cardiac extracellular matrix during b-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats. J Mol Cell Cardiol. 1998;30:1505-14.
41. Everett AD. Identification, cloning, and developmental expression of hepatoma-derived growth factor in the developing rat heart. Dev Dyn. 2001;222:450-8.
42. Abe M, Sato Y. cDNA microarray analysis of the gene expression profile of VEGF-activated human umbilical vein endothelial cells. Angiogenesis. 2001;4:289-98.
43. Yamaguchi S, Yamaguchi M, Yatsuyanagi E, Yun SS, Nakajima N, Madri JA, et al. Cyclic strain stimulates early growth response gene product 1-mediated expression of membrane type 1 matrix metalloproteinase in endothelium. Lab Invest. 2002;82:949-56.
44. Yan SF, Fujita T, Lu J. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med. 2000;6:1355-61.
45. Ten VS, Pinsky DJ. Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care. 2002;3:242-50.
46. Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet. 2002;32:490-5.